RE-BVS – Piemonte Repository

Sfoglia per RIVISTA
BMC CANCER
Collezione AOU Città della Salute di Torino

Items : 16

Acceptability of risk-based breast cancer screening among professionals and healthcare providers from 6 countries contributing to the MyPeBS study. in BMC cancer / BMC Cancer. 2025 Mar 15;25(1):483. doi: 10.1186/s12885-025-13848-z.

2025
AOU Città della Salute di Torino

Roux A; Hervouet L; Stefano FD; French DP; Giordano L; Ritchie D; Bugat MR; Keatley D; Cholerton R; McWilliams L; Rossi PG; Balleyguier C; Guindy M; Gilbert FJ; Burrion JB; Roman M; Vissac-Sabatier C; Couch D; Delaloge S; Montgolfier S;

Study protocol for Near-infrared molecular imaging for lung cancer detection and treatment during mini-invasive surgery (phase II Trial) - (the RECOGNISE study). in BMC cancer / BMC Cancer. 2024 Sep 2;24(1):1078. doi: 10.1186/s12885-024-12859-6.

2024
AOU Città della Salute di Torino

Beffa ED; Lyberis P; Rosboch GL; Arezzo A; Lococo F; Carena L; Sciorsci E; Monica V; Lausi PO; Dusi V; Busardò FP; Buffa E; Stefania R; Ciccone G; Monagheddu C; Capello BM; Vancheri R; Garrone P; Gabbarini F; Cattel F; Ruffini E; Guerrera F;

A body shape index (ABSI) is associated inversely with post-menopausal progesterone-receptor-negative breast cancer risk in a large European cohort. in BMC cancer / BMC Cancer. 2023 Jun 19;23(1):562. doi: 10.1186/s12885-023-11056-1.

2023
AOU Città della Salute di Torino

Christakoudi S; Tsilidis KK; Dossus L; Rinaldi S; Weiderpass E; Antoniussen CS; Dahm CC; Tjønneland A; Mellemkjær L; Katzke V; Kaaks R; Schulze MB; Masala G; Grioni S; Panico S; Tumino R; Sacerdote C; May AM; Monninkhof EM; Quirós JR; Bonet C; Sánchez MJ; Amiano P; Chirlaque MD; Guevara M; Rosendahl AH; Stocks T; Perez-Cornago A; Tin Tin S; et alii...

Dietary fatty acids and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition. in BMC cancer / BMC Cancer. 2023 Feb 16;23(1):159. doi: 10.1186/s12885-023-10611-0.

2023
AOU Città della Salute di Torino

Yammine SG; Huybrechts I; Biessy C; Dossus L; Panico S; Sánchez MJ; Benetou V; Turzanski-Fortner R; Katzke V; Idahl A; Skeie G; Olsen KS; Tjønneland A; Halkjaer J; Colorado-Yohar S; Heath AK; Sonestedt E; Sartor H; Schulze MB; Palli D; Crous-Bou M; Dorronsoro A; Overvad K; Gurrea AB; Severi G; Vermeulen RCH; Sandanger TM; Travis RC; Key T; et alii...

The role of sentinel node tumor burden in modeling the prognosis of melanoma patients with positive sentinel node biopsy: an Italian melanoma intergroup study (N?=?2,086). in BMC cancer / BMC Cancer. 2022 Jun 3;22(1):610. doi: 10.1186/s12885-022-09705-y.

2022
AOU Città della Salute di Torino

Tropea S; Del Fiore P; Maurichi A; Patuzzo R; Santinami M; Ribero S; Quaglino P; Caliendo V; Borgognoni L; Sestini S; Giudice G; Nacchiero E; Caracò C; Cordova A; Solari N; Piazzalunga D; Tauceri F; Carcoforo P; Lombardo M; Cavallari S; Mocellin S;

The impact of lifecourse socio-economic position and individual social mobility on breast cancer risk. in BMC cancer / BMC Cancer. 2020 Nov 23;20(1):1138. doi: 10.1186/s12885-020-07648-w.

2020
AOU Città della Salute di Torino

Berger E; Maitre N; Romana Mancini F; Baglietto L; Perduca V; Colineaux H; Sieri S; Panico S; Sacerdote C; Tumino R; Vineis P; Boutron-Ruault MC; Severi G; Castagné R; Delpierre C;

AtezoTRIBE: a randomised phase II study of FOLFOXIRI plus bevacizumab alone or in combination with atezolizumab as initial therapy for patients with unresectable metastatic colorectal cancer. in BMC cancer / BMC Cancer. 2020 Jul 22;20(1):683. doi: 10.1186/s12885-020-07169-6.

2020
AOU Città della Salute di Torino

Antoniotti C; Borelli B; Rossini D; Pietrantonio F; Morano F; Salvatore L; Lonardi S; Marmorino F; Tamberi S; Corallo S; Tortora G; Bergamo F; Brunella DS; Boccaccino A; Grassi E; Racca P; Tamburini E; Aprile G; Moretto R; Boni L; Falcone A; Cremolini C;

Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators. in BMC cancer / BMC Cancer. 2020 Aug 24;20(1):795. doi: 10.1186/s12885-020-07289-z.

2020
AOU Città della Salute di Torino

Muratov S; Canelo-Aybar C; Tarride JE; Alonso-Coello P; Dimitrova N; Borisch B; Castells X; Duffy SW; Fitzpatrick P; Follmann M; Giordano L; Hofvind S; Lebeau A; Quinn C; Torresin A; Vialli C; Siesling S; Ponti A; Giorgi Rossi P; Schünemann H; Nyström L; Broeders M;

Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial. in BMC cancer / BMC Cancer. 2019 Mar 29;19(1):283. doi: 10.1186/s12885-019-5498-3.

2019
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Ciuffreda L; Basso M; Catalano V; Bracarda S; Verusio C; Maiello E; Cinieri S; Giuliani F; Tassinari D; Frassineti GL; Spallanzani A; Bonetti A; Tortora G; Scagliotti G; Pinotti G; Tomasello G; Bertolini A; Zaniboni A; Longarini R; Luporini AG; Rimassa L; Di Costanzo F; Cardellino GG; Scartozzi M; Berardi R; Di Donato S; Lonardi S; Tamberi S; Antista M; et alii...

Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohort. in BMC cancer / BMC Cancer. 2018 Oct 22;18(1):1010. doi: 10.1186/s12885-018-4887-3.

2018
AOU Città della Salute di Torino

Sarink D; Schock H; Johnson T; Chang-Claude J; Overvad K; Olsen A; Tjønneland A; Arveux P; Fournier A; Kvaskoff M; Boeing H; Karakatsani A; Trichopoulou A; La Vecchia C; Masala G; Agnoli C; Panico S; Tumino R; Sacerdote C; van Gils CH; Peeters PHM; Weiderpass E; Agudo A; Rodríguez-Barranco M; Huerta JM; Ardanaz E; Gil L; Kaw KT; Schmidt JA; et alii...

FOXA1 and AR in invasive breast cancer: new findings on their co-expression and impact on prognosis in ER-positive patients. in BMC cancer / BMC Cancer. 2018 Jul 3;18(1):703. doi: 10.1186/s12885-018-4624-y.

2018
AOU Città della Salute di Torino

Rangel N; Fortunati N; Osella-Abate S; Annaratone L; Isella C; Catalano MG; Rinella L; Metovic J; Boldorini R; Balmativola D; Ferrando P; Marano F; Cassoni P; Sapino A; Castellano I; Rangel N; Fortunati N; Osella-Abate S; Annaratone L; Isella C; Catalano MG; Rinella L; Metovic J; Boldorini R; Balmativola D; Ferrando P; Marano F; Cassoni P; Sapino A; et alii...

Diabetes and risk of cancer incidence: results from a population-based cohort study in northern Italy. in BMC cancer / BMC Cancer. 2017 Oct 25;17(1):703. doi: 10.1186/s12885-017-3696-4.

2017
AOU Città della Salute di Torino

Ballotari P; Vicentini M; Manicardi V; Gallo M; Chiatamone Ranieri S; Greci M; Giorgi Rossi P;

The ANDROMEDA prospective cohort study: predictive value of combined criteria to tailor breast cancer screening and new opportunities from circulating markers: study protocol. in BMC cancer / BMC Cancer. 2017 Nov 22;17(1):785. doi: 10.1186/s12885-017-3784-5.

2017
AOU Città della Salute di Torino

Giordano L; Gallo F; Petracci E; Chiorino G; Segnan N;

Incorporating (18)FDG-PET-defined pelvic active bone marrow in the automatic treatment planning process of anal cancer patients undergoing chemo-radiation. in BMC cancer / BMC Cancer. 2017 Nov 2;17(1):710. doi: 10.1186/s12885-017-3708-4.

2017
AOU Città della Salute di Torino

Franco P; Fiandra C; Arcadipane F; Trino E; Giglioli FR; Ragona R; Ricardi U;

Diet and endometrial cancer: a focus on the role of fruit and vegetable intake, Mediterranean diet and dietary inflammatory index in the endometrial cancer risk. in BMC cancer / BMC Cancer. 2017 Nov 13;17(1):757. doi: 10.1186/s12885-017-3754-y.

2017
ASL Torino 3
AOU Città della Salute di Torino

Sacerdote C; Fiorini L; Sciannameo V; Milanese D; Fasanelli F; Giraudo MT; Ricceri F;

Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation. in BMC cancer / BMC Cancer. 2015 Dec 24;15:1009. doi: 10.1186/s12885-015-2025-z.

2015
AOU Città della Salute di Torino

Grange C; Tapparo M; Tritta S; Deregibus MC; Battaglia A; Gontero P; Frea B; Camussi G;